Intuitive Surgical, Inc. $ISRG Shares Acquired by SteelPeak Wealth LLC

SteelPeak Wealth LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 28.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 41,993 shares of the medical equipment provider’s stock after purchasing an additional 9,364 shares during the quarter. SteelPeak Wealth LLC’s holdings in Intuitive Surgical were worth $18,781,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Norges Bank acquired a new position in shares of Intuitive Surgical in the second quarter worth about $2,569,260,000. Vanguard Group Inc. grew its stake in Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after purchasing an additional 670,302 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Intuitive Surgical by 20.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock valued at $1,680,922,000 after purchasing an additional 566,979 shares in the last quarter. Jennison Associates LLC raised its position in shares of Intuitive Surgical by 20.4% in the 2nd quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock valued at $1,696,738,000 after purchasing an additional 528,359 shares in the last quarter. Finally, Bessemer Group Inc. boosted its stake in shares of Intuitive Surgical by 89.3% during the 2nd quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock valued at $428,386,000 after buying an additional 371,806 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 1.1%

Shares of ISRG stock opened at $566.36 on Friday. The company has a market cap of $203.03 billion, a P/E ratio of 74.92, a PEG ratio of 5.18 and a beta of 1.67. The business has a 50 day moving average of $561.16 and a two-hundred day moving average of $508.68. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm’s revenue was up 22.9% on a year-over-year basis. During the same period in the prior year, the business earned $1.84 EPS. Analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research analyst reports. Royal Bank Of Canada lifted their price target on shares of Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Sanford C. Bernstein restated an “outperform” rating and issued a $685.00 target price on shares of Intuitive Surgical in a research note on Tuesday, October 21st. Robert W. Baird set a $655.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Citigroup lowered Intuitive Surgical from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $650.00 to $635.00 in a report on Thursday, December 11th. Finally, Mizuho set a $575.00 target price on Intuitive Surgical in a report on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $611.08.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 22,806 shares of the business’s stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $570.89, for a total transaction of $13,019,717.34. Following the completion of the transaction, the insider directly owned 2,694 shares of the company’s stock, valued at $1,537,977.66. The trade was a 89.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Mark Brosius sold 464 shares of the stock in a transaction on Monday, December 15th. The stock was sold at an average price of $548.49, for a total value of $254,499.36. Following the completion of the transaction, the senior vice president directly owned 131 shares of the company’s stock, valued at approximately $71,852.19. The trade was a 77.98% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 114,007 shares of company stock worth $63,533,844 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.